AU8979698A - Solutions containing azasteroids - Google Patents

Solutions containing azasteroids

Info

Publication number
AU8979698A
AU8979698A AU89796/98A AU8979698A AU8979698A AU 8979698 A AU8979698 A AU 8979698A AU 89796/98 A AU89796/98 A AU 89796/98A AU 8979698 A AU8979698 A AU 8979698A AU 8979698 A AU8979698 A AU 8979698A
Authority
AU
Australia
Prior art keywords
azasteroids
solutions containing
solutions
containing azasteroids
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU89796/98A
Other languages
English (en)
Inventor
Alan Frank Parr
Michele Catherine Rizzolio
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of AU8979698A publication Critical patent/AU8979698A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU89796/98A 1997-08-19 1998-08-17 Solutions containing azasteroids Abandoned AU8979698A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9717444 1997-08-19
GBGB9717444.5A GB9717444D0 (en) 1997-08-19 1997-08-19 Pharmaceutical composition
PCT/EP1998/005192 WO1999008684A2 (fr) 1997-08-19 1998-08-17 Solutions contenant des azasteroïdes

Publications (1)

Publication Number Publication Date
AU8979698A true AU8979698A (en) 1999-03-08

Family

ID=10817633

Family Applications (1)

Application Number Title Priority Date Filing Date
AU89796/98A Abandoned AU8979698A (en) 1997-08-19 1998-08-17 Solutions containing azasteroids

Country Status (10)

Country Link
EP (1) EP1005346A2 (fr)
JP (1) JP2002511100A (fr)
KR (1) KR20010014079A (fr)
CN (1) CN1263466A (fr)
AU (1) AU8979698A (fr)
BR (1) BR9810285A (fr)
CA (1) CA2295023A1 (fr)
GB (1) GB9717444D0 (fr)
TR (1) TR199903211T2 (fr)
WO (1) WO1999008684A2 (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IS6633A (is) * 2002-11-22 2004-05-23 Omega Farma Ehf. Samsetningar af fínasteríð töflum
CZ300438B6 (cs) * 2003-11-25 2009-05-20 Pliva Hrvatska D.O.O. Zpusob prípravy orální pevné lékové formy s okamžitým uvolnováním úcinné látky obsahující jako úcinnou látku polymorfní formu finasteridu
JP2007517788A (ja) * 2004-01-02 2007-07-05 ファルマコン・フォルシュング・ウント・ベラートゥング・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング １，２−不飽和アザステロイド類の製造方法
EP2050436A1 (fr) 2007-12-21 2009-04-22 Siegfried Generics International AG Composition pharmaceutique qui comporte de la dutastéride
DE102008059201A1 (de) * 2008-11-27 2010-06-02 GÖPFERICH, Achim, Prof. Dr. In situ präzipitierende Arzneistofflösungen
KR101055412B1 (ko) * 2010-11-19 2011-08-08 (주)비씨월드제약 두타스테라이드를 포함하는 자가유화 에멀젼 조성물 및 이의 제조방법
CN103169712B (zh) * 2011-12-20 2017-10-27 重庆华邦制药有限公司 提高生物利用度的度他雄胺制剂及其制备方法
CN104619345A (zh) * 2012-05-18 2015-05-13 罗达制药有限公司 液体制剂
CN103479595B (zh) * 2012-06-13 2015-08-26 成都国弘医药有限公司 一种含有度他雄胺的软胶囊
WO2014002015A1 (fr) 2012-06-25 2014-01-03 Ranbaxy Laboratories Limited Composition pharmaceutique comprenant du dutastéride
CN103830201A (zh) * 2012-11-20 2014-06-04 重庆医药工业研究院有限责任公司 一种度他雄胺液体软胶囊
EP2949319A1 (fr) 2014-05-26 2015-12-02 Galenicum Health S.L. Compositions pharmaceutiques comprenant un agent actif
JP7017938B2 (ja) * 2018-01-15 2022-02-09 森下仁丹株式会社 ３－オキソ－４－アザアンドロスト－１－エン－１７－カルボン酸誘導体含有製剤

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5516768A (en) * 1990-03-16 1996-05-14 Smithkline Beecham Corporation Uncompetitive inhibition of steroid and 5α-reductose
US5300294A (en) * 1990-06-27 1994-04-05 Smithkline Beecham Corporation Method of treating prostatic adenocarcinoma
TW408127B (en) * 1993-09-17 2000-10-11 Glaxo Inc Androstenones
CA2231434A1 (fr) * 1995-09-27 1997-04-03 Glenn J. Gormley Methode de prevention de l'alopecie androgenetique par des inhibiteurs de la 5-.alpha. reductase
WO1998025463A1 (fr) * 1996-12-09 1998-06-18 Merck & Co., Inc. Procedes et compositions permettant de prevenir et de traiter la perte osseuse

Also Published As

Publication number Publication date
EP1005346A2 (fr) 2000-06-07
CA2295023A1 (fr) 1999-02-25
WO1999008684A2 (fr) 1999-02-25
TR199903211T2 (xx) 2000-04-21
BR9810285A (pt) 2000-09-12
KR20010014079A (ko) 2001-02-26
GB9717444D0 (en) 1997-10-22
CN1263466A (zh) 2000-08-16
WO1999008684A3 (fr) 1999-06-10
JP2002511100A (ja) 2002-04-09

Similar Documents

Publication Publication Date Title
AU1709299A (en) Mixer-injectors
AU8921698A (en) Follistatin-3
AU9414098A (en) Ascorbyl-phosphoryl-cholesterol
AU6598798A (en) Resorcinyl-triazines
AU1027499A (en) 32P-polyphosphazene
AU9513298A (en) Fluoranthenopyrans
AU5272198A (en) EMP-charge-eliminator
AU8979698A (en) Solutions containing azasteroids
AU4117497A (en) Micropolarimeter
AU6998698A (en) Dioxacycloalkan-8-one
AU6185898A (en) Clavaspirins
AU7761998A (en) Korrosionsschutzanstrichstoff
AU8214598A (en) 3-benzylpiperidine
AU9183798A (en) Catamaran - bicycle - kayak
AU4469997A (en) Heregulin-gamma
AU8991998A (en) Renovative pipeliner
AU5391798A (en) Thiamacrolides
AU5540298A (en) Rockbolts
AU6507298A (en) Renovative pipeliner
AU6237398A (en) N-het-substituted glycerophosphoethanolamines
AU7780498A (en) Cafetiere
AU8121298A (en) G-seat
AU6060598A (en) Multi-hopper
AUPO561397A0 (en) Rota-screed
AUPO569197A0 (en) Rotafuse / multifuse

Legal Events

Date Code Title Description
MK3 Application lapsed section 142(2)(c) - examination deferred under section 46 no request for examination